Literature DB >> 11677955

Immunohistochemical expression of extracellular matrix proteins and adhesion molecules in pancreatic carcinoma.

S Linder1, E Castaños-Velez, A von Rosen, P Biberfeld.   

Abstract

BACKGROUND/AIMS: Carcinoma invasion and metastasis in general involve multiple steps including dynamic changes in the composition and structure of extracellular matrix proteins and cell surface receptors. In the present study, the usually highly invasive carcinoma of the pancreas was investigated regarding the expression of various extracellular matrix proteins and their corresponding integrin receptors, as well as E-cadherin.
METHODOLOGY: Phenotypic expression of various markers was investigated immunohistochemically in frozen sections of 16 pancreatic carcinomas and normal pancreatic tissue.
RESULTS: An irregular and discontinuous deposition of type IV collagen and laminin in the basement membrane was found in cancer tissue and a pronounced desmoplastic reaction with deposition of type I, type III, and type IV collagen in the tumor stroma. In contrast, the noninvolved pancreas showed an intact basement membrane and a sparse stroma. The collagen type IV and laminin receptors alpha 2, alpha 3, and beta 1 integrin subunits were expressed on pancreatic cancer cells but not the alpha 6 integrin subunit normally present on epithelial cells, suggesting anchorage independence of the carcinoma cells. An increased capacity for cancer cell motility was suggested by the abundant expression of the "antiadhesive" extracellular matrix proteins, tenascin and vitronectin close to the cancer cells, and the expression of cell surface receptors such as alpha v (vitronectin-binding). Expression of the alpha 4 integrin subunit was also increased on cancer cells.
CONCLUSIONS: The distribution of extracellular matrix proteins and the cell surface immune phenotype differed in pancreatic carcinoma as compared to normal pancreatic tissue. The present findings substantiate the notion that disseminated growth of highly malignant carcinomas of the pancreas reflects an invasive interaction of the tumor cells with extracellular matrix proteins of a well-established stroma. Similar findings were observed regardless of tumor histology and patient survival time.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11677955

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  39 in total

1.  Expression and prognostic significance of CD151, c-Met, and integrin alpha3/alpha6 in pancreatic ductal adenocarcinoma.

Authors:  Guang-Hui Zhu; Chen Huang; Zheng-Jun Qiu; Jun Liu; Zhi-Hua Zhang; Ning Zhao; Zheng-Zhong Feng; Xiu-Hong Lv
Journal:  Dig Dis Sci       Date:  2010-10-07       Impact factor: 3.199

2.  Type I collagen and divalent cation shifts disrupt cell-cell adhesion, increase migration, and decrease PTHrP, IL-6, and IL-8 expression in pancreatic cancer cells.

Authors:  John J Grzesiak; Kathy C Smith; Cheryl Chalberg; Douglas W Burton; Leonard J Deftos; Michael Bouvet
Journal:  Int J Gastrointest Cancer       Date:  2005

3.  αv integrin: a new gastrin target in human pancreatic cancer cells.

Authors:  Celine Cayrol; Claudine Bertrand; Aline Kowalski-Chauvel; Laurence Daulhac; Elizabeth Cohen-Jonathan-Moyal; Audrey Ferrand; Catherine Seva
Journal:  World J Gastroenterol       Date:  2011-10-28       Impact factor: 5.742

Review 4.  Tumor-stromal interactions in pancreatic cancer.

Authors:  Clifford Whatcott; Haiyong Han; Richard G Posner; Daniel D Von Hoff
Journal:  Crit Rev Oncog       Date:  2013

5.  Divalent cations modulate alpha2beta1 integrin-mediated malignancy in a novel 3-dimensional in vitro model of pancreatic cancer.

Authors:  John J Grzesiak; Fabian Vargas; Michael Bouvet
Journal:  Pancreas       Date:  2010-08       Impact factor: 3.327

6.  Tenascin C expression is upregulated in pancreatic cancer and correlates with differentiation.

Authors:  A Juuti; S Nordling; J Louhimo; J Lundin; C Haglund
Journal:  J Clin Pathol       Date:  2004-11       Impact factor: 3.411

7.  Type IV collagen is a tumour stroma-derived biomarker for pancreas cancer.

Authors:  D Ohlund; C Lundin; B Ardnor; M Oman; P Naredi; M Sund
Journal:  Br J Cancer       Date:  2009-06-02       Impact factor: 7.640

Review 8.  Key players in pancreatic cancer-stroma interaction: Cancer-associated fibroblasts, endothelial and inflammatory cells.

Authors:  Michael Friberg Bruun Nielsen; Michael Bau Mortensen; Sönke Detlefsen
Journal:  World J Gastroenterol       Date:  2016-03-07       Impact factor: 5.742

Review 9.  Orchestrating the Tumor Microenvironment to Improve Survival for Patients With Pancreatic Cancer: Normalization, Not Destruction.

Authors:  Clifford J Whatcott; Haiyong Han; Daniel D Von Hoff
Journal:  Cancer J       Date:  2015 Jul-Aug       Impact factor: 3.360

10.  Integrin-mediated laminin-1 adhesion upregulates CXCR4 and IL-8 expression in pancreatic cancer cells.

Authors:  John J Grzesiak; Kathy C Smith; Douglas W Burton; Leonard J Deftos; Michael Bouvet
Journal:  Surgery       Date:  2007-05-04       Impact factor: 3.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.